Managing community acquired pneumonia in the elderly – the next generation of pharmacotherapy on the horizon-Reference-Cited by-同舟云学术

Managing community acquired pneumonia in the elderly – the next generation of pharmacotherapy on the horizon

Published:2017-06-21 Issue:11 Volume:18 Page:1039-1048
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Amalakuhan B¹²,Echevarria KL¹²,Restrepo MI¹²

Affiliation:

1. Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Texas Health Science Center San Antonio, San Antonio, TX, USA

2. Department of Medicine, Division of Pulmonary and Critical Care Medicine, South Texas Veterans Health Care System, San Antonio, TX, USA

Funder

National Heart, Lung, and Blood Institute

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2017.1340937

Reference35 articles.

1. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

2. Management of community-acquired pneumonia: a review and update

3. Epidemiology of community-acquired pneumonia in older adults: A population-based study

4. Guidelines for the management of adult lower respiratory tract infections - Summary

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shen-Ling-Bai-Zhu-San Enhances the Antipneumonia Effect of Cefixime in Children by Ameliorating Gut Microflora, Inflammation, and Immune Response;Evidence-Based Complementary and Alternative Medicine;2022-09-07

2. Impact of establishing a respiratory high dependency unit for SCAP patients on the therapeutic effect, prognosis, and expenditure: a retrospective case–control study;Scientific Reports;2022-06-23

3. Community-acquired pneumonia;The Lancet;2021-09

4. Lefamulin efficacy and safety in a pooled phase 3 clinical trial population with community-acquired bacterial pneumonia and common clinical comorbidities;BMC Pulmonary Medicine;2021-05-08

5. Updates on community acquired pneumonia management in the ICU;Pharmacology & Therapeutics;2021-01